Zoetis Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
Business Address 10 SYLVAN WAY, PARSIPPANY, NJ, 07054
Mailing Address 10 SYLVAN WAY, PARSIPPANY, NJ, 07054
Phone 973-822-7000
Fiscal Year End 1231
EIN 460696167
Financial Overview
FY2025
$4.77B
Stockholders' Equity
$6.03
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 12, 2026 | View on SEC |
| 10-K Annual financial report | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
| 4 Insider stock transaction report | February 10, 2026 | View on SEC |
Annual Reports
10-K February 12, 2026
- Zoetis delivered robust 2024 financial performance with $8.5 billion revenue (up 4.9%) and $2.1 billion net income (up 12%), primarily driven by strong companion animal demand.
- The company maintains market leadership in global animal health, supported by a diversified product portfolio, extensive global reach, and strong customer relationships.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.